The global synthetic biosensors market involves the development and use of synthetic biomaterials for biosensing applications. Synthetic biosensors employ man-made materials such as electrodes, optical tags, microfluidic chips and nanoparticles for the detection of chemical and biological analytes including glucose, DNA, proteins, and other molecules. They provide advantages over natural biological materials such as improved stability, reproducibility and longevity. Synthetic biosensors are of special interest for applications in the healthcare sector including disease diagnostics, drug development, personalized medicine and remote patient monitoring.

The Global Synthetic Biosensors Market is estimated to be valued at US$ 27.94 Bn in 2024 and is expected to exhibit a CAGR of 7.3% over the forecast period 2024 to 2031.

Key Takeaways

Key players operating in the Global Synthetic Biosensors Market Size are TIVIC HEALTH, Cala Health, Inc., Medtronic, Abbott, Spark Biomedical, Inc., BioElectronics, GENERAL ELECTRIC, BIOTRONIK, electroCore, Inc., Soterix Medical Inc, SetPoint Medical, NeuroEM Therapeutics, ReShape Lifesciences, Inc., NeuroSpine, Vivani Medical Inc., Boston Scientific Corporation, NEVRO CORP., and Salvia BioElectronics. Key players are focusing on investments in R&D to develop advanced miniaturized biosensing platforms with improved sensitivity and selectivity.

The demand for synthetic biosensors is growing significantly driven by the increasing prevalence of chronic and lifestyle diseases globally. Rapid diagnostic testing and non-invasive monitoring are becoming integral parts of healthcare systems worldwide. Synthetic biosensors allow for cost-effective and scalable solutions for point-of-care and home-based diagnostic applications.

Geographically, North America dominated the global synthetic biosensors market in 2024. However, the market in Asia Pacific is expected to witness the highest CAGR during the forecast period. This can be attributed to expanding healthcare infrastructure, rising medical tourism, and growing investment by public and private organizations in countries such as China and India.

Market Drivers

Miniaturization and portability is a key driver propelling the synthetic biosensors market growth. The development of nanotechnology has allowed the miniaturization of biosensing components including electrodes, probes and signal processors. Miniaturized biosensors have significant advantages in terms of portability, affordability and ease of use. This makes them well-suited for applications such as continuous glucose monitoring, ambulatory monitoring of vital signs and rapid field testing. Miniaturized synthetic biosensors are expected to play a crucial role in democratizing healthcare through decentralized diagnostics and remote monitoring.

Impact of geopolitical situation on the growth of Global Synthetic Biosensors Market
The current geopolitical environment has led to decreased globalization and rising trade barriers between major economies like the US, China and Europe. This has impacted transnational collaborations and access to key resources for biosensor development. Many countries have also focussed on developing indigenous capabilities to reduce dependence on imports. As a result, funding for local R&D in synthetic biology and bioelectronics has increased substantially.

Get more insights on Global Synthetic Biosensors Market

Also read related article on Industrial Filter Market